• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌眼眶转移:单机构病例系列。

Orbital metastases from breast cancer: A single institution case series.

机构信息

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Italy.

Department of Human Pathology in Adulthood and Childhood "G. Barresi", University Hospital of Messina, Italy.

出版信息

J Surg Oncol. 2020 Aug;122(2):170-175. doi: 10.1002/jso.25927. Epub 2020 Apr 15.

DOI:10.1002/jso.25927
PMID:32297325
Abstract

BACKGROUND AND OBJECTIVES

Among orbital tumors, metastatic lesions have a prevalence of 1% to 13%; on the other hand, breast cancer is the most common malignancy causing orbital metastases. The aim of this study is to present our experience dealing with orbital metastases caused by breast cancer, to assess characteristics and clinic-pathological data of patients suffering from this rare occurrence and to find indexes related with their prognosis and survival.

METHODS

Records of 28 patients diagnosed with orbital metastases from breast cancer at the Department of Ophthalmology, Humanitas Clinical and Research Centre of Milano over a 27-year period (1992-2018) were retrieved and analyzed.

RESULTS

Mean patients' age at breast cancer diagnosis was 56.29 ± 14.63 years. Mean time interval between breast cancer diagnosis and orbital metastasis occurrence was 5 ± 4.17 years. All lesions were estrogen receptor-positive; 79% of patients harbored progesterone receptor-positive lesions. Interestingly, the majority of deceased patients presented orbital lesions with MIB-1 index >50% (P = .0265) and had concomitant lung metastases (P = .0452).

CONCLUSIONS

The occurrence of orbital metastasis from breast cancer represents a challenging finding. Patients' clinical picture can include exophthalmos, edema, tumefaction, proptosis and/or diplopia. Significant symptomatic improvement can be achieved through surgery and other adjuvant treatments, such as radiation therapy and chemotherapy.

摘要

背景与目的

在眼眶肿瘤中,转移性病变的患病率为 1%至 13%;另一方面,乳腺癌是导致眼眶转移的最常见恶性肿瘤。本研究旨在介绍我们在处理乳腺癌引起的眼眶转移方面的经验,评估患有这种罕见疾病的患者的特征和临床病理数据,并找到与预后和生存相关的指标。

方法

检索了 2018 年在米兰 Humanitas 临床与研究中心眼科诊断为乳腺癌眼眶转移的 28 例患者的记录,并进行了分析。

结果

乳腺癌诊断时患者的平均年龄为 56.29±14.63 岁。乳腺癌诊断与眼眶转移发生之间的平均时间间隔为 5±4.17 年。所有病变均为雌激素受体阳性;79%的患者孕激素受体阳性病变。有趣的是,大多数死亡患者的眼眶病变 MIB-1 指数>50%(P=0.0265),且同时伴有肺转移(P=0.0452)。

结论

乳腺癌眼眶转移的发生是一个具有挑战性的发现。患者的临床表现可能包括眼球突出、水肿、肿胀、眼球突出和/或复视。通过手术和其他辅助治疗,如放射治疗和化疗,可以显著改善症状。

相似文献

1
Orbital metastases from breast cancer: A single institution case series.乳腺癌眼眶转移:单机构病例系列。
J Surg Oncol. 2020 Aug;122(2):170-175. doi: 10.1002/jso.25927. Epub 2020 Apr 15.
2
Periocular Breast Carcinoma Metastases: Predominant Origin From the Lobular Variant.眼周乳腺癌转移:主要起源于小叶型变异体。
Ophthalmic Plast Reconstr Surg. 2017 Sep/Oct;33(5):361-366. doi: 10.1097/IOP.0000000000000793.
3
High frequency of lobular breast cancer in distant metastases to the orbit.小叶性乳腺癌远处转移至眼眶的高发生率。
Cancer Med. 2015 Jan;4(1):104-11. doi: 10.1002/cam4.331. Epub 2014 Oct 30.
4
Orbital metastases from breast cancer: A retrospective analysis of 28 cases.乳腺癌眼眶转移:28 例回顾性分析。
Cancer Treat Res Commun. 2020;24:100184. doi: 10.1016/j.ctarc.2020.100184. Epub 2020 Jun 16.
5
Orbital Metastases from Breast Cancer: Retrospective Analysis at an Academic Cancer Center.乳腺癌眼眶转移:一所学术性癌症中心的回顾性分析
Breast J. 2016 Jul;22(4):447-50. doi: 10.1111/tbj.12604. Epub 2016 May 3.
6
Metastatic Orbital Tumor From Breast Ductal Carcinoma With Neuroendocrine Differentiation Initially Presenting as Ocular Symptoms: A Case Report and Literature Review.转移性乳腺导管癌伴神经内分泌分化眶内肿瘤:以眼部症状首发的病例报告及文献复习。
Front Endocrinol (Lausanne). 2021 Feb 22;12:625663. doi: 10.3389/fendo.2021.625663. eCollection 2021.
7
[Orbital metastases of breast cancer].[乳腺癌的眼眶转移]
An Sist Sanit Navar. 2008;31 Suppl 3:135-45.
8
Study of aggressive carcinomas through orbital metastasis.通过眼眶转移对侵袭性癌的研究。
Arch Soc Esp Oftalmol (Engl Ed). 2019 May;94(5):252-256. doi: 10.1016/j.oftal.2018.10.012. Epub 2018 Dec 19.
9
An unusual orbital metastasis of breast cancer.一例罕见的乳腺癌眼眶转移
Breast Dis. 2014 Jan 1;34(4):173-6. doi: 10.3233/BD-140367.
10
Orbital metastases of invasive lobular breast carcinoma.浸润性小叶乳腺癌的眼眶转移
Breast Dis. 2019;38(3-4):85-91. doi: 10.3233/BD-190398.

引用本文的文献

1
Iatrogenic Ocular Surface Complications After Surgery for Ocular and Adnexal Tumors.眼及附属器肿瘤手术后的医源性眼表并发症
Cancers (Basel). 2025 Apr 22;17(9):1384. doi: 10.3390/cancers17091384.
2
From Breast to Orbit: A Case Report of Metastatic Breast Cancer With Orbital Involvement.从乳腺到眼眶:一例伴有眼眶转移的转移性乳腺癌病例报告。
Cureus. 2024 Aug 15;16(8):e66927. doi: 10.7759/cureus.66927. eCollection 2024 Aug.
3
Orbital Metastases: A Systematic Review of Clinical Characteristics, Management Strategies, and Treatment Outcomes.
眼眶转移瘤:临床特征、管理策略及治疗结果的系统评价
Cancers (Basel). 2021 Dec 24;14(1):94. doi: 10.3390/cancers14010094.
4
Late orbital metastasis from colon cancer complicated by multiple tumors in the breast, lung, liver, and spine.结肠癌晚期眼眶转移,合并乳腺、肺、肝和脊柱多发肿瘤。
Radiol Case Rep. 2021 Oct 28;17(1):5-12. doi: 10.1016/j.radcr.2021.09.057. eCollection 2022 Jan.
5
Pitfalls in diagnosing orbital malignancy through orbital incisional biopsy: A report of two cases with different scenarios.经眼眶切开活检诊断眼眶恶性肿瘤的陷阱:两例不同情况的报告
Saudi J Ophthalmol. 2021 Feb 27;34(3):205-208. doi: 10.4103/1319-4534.310420. eCollection 2020 Jul-Sep.
6
An early orbital metastasis from breast cancer: A case report.一例早期乳腺癌眼眶转移病例报告
Int J Surg Case Rep. 2021 Jan;78:300-302. doi: 10.1016/j.ijscr.2020.12.049. Epub 2020 Dec 18.
7
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology.乳腺癌眼眶及眶周转移患者的治疗及预后:一项综合病例系列研究,包括对小叶性与导管性肿瘤组织学的分析。
Breast Cancer Res. 2020 Jun 26;22(1):70. doi: 10.1186/s13058-020-01309-3.